Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Even though the markets took a beating over the past week and biotech stocks experienced a broader industry sell-off, one stock in this space stood out as the clear winner on the market on Monday. Shares of Oramed Pharmaceuticals were up more than 25% today, ahead of the company's report of phase 2 results for its oral insulin drug 0801 on Jan. 30.
http://www.dailyfinance.com/2014/01/27/oramed-pharmaceuticals-mondays-top-stock/
I wonder how many diabetics they have actually asked if they want to inhale insulin?
http://www.dailyfinance.com/2014/01/27/oramed-pharmaceuticals-mondays-top-stock/
I wonder how many diabetics they have actually asked if they want to inhale insulin?